moderna shares are moving fast.t now on this 94.5% effective news from moderna. dr. adalja, great to see you this morning. thank you very much for calling in. we'll slip in a short break. when we come back, the latest on pfizer's covid-19 vaccine as well. we're going to look at sigh ser versus-car phi -- pfizer versus moderna. one new york state senator was part of the pfizer trial. he'll join us next. your costco membership could send you soaring on a private jet, the retailer's expensive new plan coming up. stay with us. this is andy, my schwab financial consultant. here's andy listening to my goals and making plans. this is us talking tax-smart investing, managing risk, and all the ways schwab can help me invest. this is andy reminding me how i can keep my investing costs low and that there's no fee to work with him. here's me learning about schwab's satisfaction guarantee. accountability, i like it. so, yeah. andy and i made a good plan. find your own andy at schwab. a modern approach to wealth management. find

moderna plans to apply soon after it accumulates more safety data. pfizer said its vaccine was 90 pe90% effective. "today in the bay's" jackie ward following the struggles facing new rollbacks. >> let's begin with tracie potts. tracie, i know any response from the president or even the president-elect yet on the moderna news? >> reporter: the president has suggested that maybe this news had been held back until after the election. again, no evidence of that. the president-elect, the biden transition team, is actually meeting with some of the drug makers this week to talk about these vaccines but what they're not doing is meeting with the trump team, the government officials, to talk about distributing the vaccine. developing it is one thing but getting it out to you, your neighborhood, your familiar si, your doctor's office a differently. that cooperation is not happening while the president continues to challenge the results and not direct his administration to work with the biden team. joe biden not getting intelligence briefs as the situation gets

vaccine has done, as the moderna vaccine has done, as the moderna vaccine has done.rking against. and, you know, when we started this journey back in february, march, we didn't even know that, so, yes, we are feeling in a happier place than we were. but do we know the data? no, we don't. we are not there yet. catherinejones from channel five. secretary of state, thank you. you said in response to diviya's question, the end of the england lock down, that it was too early to see in the data whether additional measures would be needed, but the sage subgroup has reported to you that england are returning tojust three reported to you that england are returning to just three tiers on december the r value rising again and would damage any potential decline in numbers you do begin to see. with hospitals already under intense pressure, this could put strain on them: back utterly to come mid decemberso! strain on them: back utterly to come mid december so i am wondering what measures mid december you are arguing for within government on behalf of the nhs and in in order to pre

moderna expects to have about 20 million vaccines available to the u.s. by the end of the year and pfizer and his german partner expect 50 million by the end of the year. paris. >> harris: laura, thank you very much. part of a good new stream today, good to see you, my friend. trump campaign director of press communications aaron perini is with me. good to see you today. first of all, let's stay on the good news train. it feels so good. talk to me a little bit, i know from what i've read that you are still doing some messaging around this. as you are fighting in the courts and whatnot, they are still getting the message out to trump supporter's and what is it today about not just one, but to vaccines in the last week that have been announced? >> absolutely, harris always good to be on with you, thank you for having me today. you're right, the good news is pouring in on president trump's operation warp speed. the government allowing business and enterprise and medical innovation to lead the way for not one, but two vaccines against the coronavirus. thanks

it is all about moderna as the

in terms of moderna it traded ten times the normal volume today so enjoy the ride with moderna. >> nothing to say they won't have another offering in the future with the stock close to $100 as tim made the point, other vaccines, if you thought betting on mra technology was a binary outcome you just got a little bit more confidence that this could actually work. >> yeah. look two different companies, two different sets of data, two different sets after approaches. what moderna has done is extraordinary. what is critical is style points, if the company is as close as it sounds than maybe that was all the right approach. moder moderna, granted pulled back today here, it's clear they've been the only one to be a proper investment conduit for folks playing vaccines gill iatrcan't get out of its way and in the process has made a major acquisition. anything, yes, the trading the vaccine has been all about trading the downstream look at the stocks today that made highs over their highs of monday that's the interesting story it was energy. it was boeing. it was copper. it was resource stocks it was

. >> ademas la buena noticia en l carrera contra el ccovid-19, l o laboratorios moderna anuncian queuna tiene un 95% de f eficacia, podría estar lista lo próximos meses que gane el trabaj es la segunda vacuna contra el c coronavirus que esta casi lista la pregunta es que tan seguras son y cunaando podremos tener u dosis la advertencia de bidejoe bide,l presidente asegura que más personas podría morir por la pandemia si donald trump no co p coopera con la transición del poder, cada día estados unidos rompe el récord de contagios >> y un viaje Único llega a la estación espacial internacional la nave de space x que salió este domingo desde florida, los cuatro astronautas terminan una misión histórica, es la primera operación de la nasa con una empresa privada y no es poca cosa , algunos dicen que esta noche comienza una nueva era en la exploración espacial, tenemos la información, pero antes tenemos al huracán iot (musica( (musica( sin tiempo para recuperarse del desastre que eta causo hace menos de dos semanas, centroamérica recibe el impacto del huracán iota categoría cuatro, tocó tie

this time it comes from moderna. the coronavirus vaccine they are developing is found to be 94% effective in analysis. some encouraging signs around the storage of that as well. off to the races before the news, and off to the races after it. tom: i am going to set it just below the enthusiasm that we saw with the pfizer lift, and that may change. i am looking at dow. i know look -- i know john publix at s&p 5 -- i know jon looks at s&p 500. we are not on speaking terms about that. will we get there i say a 21 vix? jonathan: i think it is fair to say we are from different generations. we can't imagine the vix is going to go a little bit lower on this. the nasdaq, that is the story we should sit on for just a moment. we are pretty much unchanged on the session. it is that tug-of-war still. how may times did we have that chat last week, the tug-of-war between the near-term risks, the long-term opportunity, between big tech and small-cap value? lisa: a lot of people are going to be asking the question, will the big tech

solicita a la fda autorizaciÓn emergencia de la vacuna y moderna avala la peticiÓn de no le impide estacasa blanca >>> raÚl jimÉnez se recupera de su coche con el crÁneo fracturado. la pandemia anima hacer mÁs compras por internet y el tenor de posibles estafa le damos claves para evitar sustos. ( ♪ mÚsica ♪ ) >>> hola cÓmo estÁn buenas tardes. les saluda felicidad aveleyra gracias por acompaÑarnos. hay nueva peticiÓn a la fda de vÍa libre para otra vacuna contra el covid tambiÉn de emergencia como pfizer y lo hace moderna luego que el dÍa de contagios aumentan con 13 mil millones de casos y 266 mil muertes pero volvamos con moderna rogelio. >>> sÍ pfizer lo hizo el 22 de noviembre y moderna dice en su data mÁs reciente tiene efectividad del 94. 1% entonces serÍa introducida hoy misma y el 17 de diciembre estarÍa siendo sometida a una anÁlisis final por parte de la administraciÓn de drogas y alimentos si ellos dan la luz verde estarÍan en la posibilidad de compr comenzar a describirse, tendrÍamos alrededor de 60 millones de dosis que estarÍa a disposiciÓn de las personas, lo interesante

the dow hitting an all-time highs a thigh as the record rally goes on, as moderna says its vaccine is nearly 95% effective moderna up 9%, 10% right now while the other vaccine stocks are actually dipping we are awaiting president-elect bide wren to give remarks about state of the economy after meeting with top business leaders and ceos today we'll get you there when it happens as "power lunch" starts right now. >>> thank you, ty. the dow was soaring to all-time highs, just shy of 30,000 today. all signs pointing to a continued rally except for one, a very important one let's go to bob pisani for more on that. bob? >> we are seeing that moderna is helping the market overall and continuing a trend that we saw for the last really week and a half let's take a look at the sectors here the story is value-like banks and energy stocks has been outperforming growth areas like technology for example nen we've seen cyclical sectors like industrials, for example. generally outperforming defensive sectors like consumer staples. generally small caps have been outperforming big caps in is this is a

ont was the chair of moderna fascinating vaccine development.g up another historic lunch for spacex and their lunch. a real-life astronaut will be joining us. that is next. this is bloomberg. ♪ businesses today are looking to tomorrow. adapting. innovating. setting the course. but new ways of working demand a new type of network. one that's more than just fast. you need flexibility- to work from anywhere. and manage from everywhere. advanced technology. with serious security. and reliable coverage, nationwide. forward-thinking enterprises, deserve forward-thinking solutions. and that's what we deliver. so bounce forward, with comcast business. spacex hitting a huge milestone this past weekend. elon musk's company launching its first regular nasa mission to the international space station. four astronauts took off from cape canaveral on sunday and will dock around 11:00 p.m. eastern tonight. joining us now for more thomas space shuttletime pilot. my kids and i were watching last night. they were so excited. it is almost as if nasa is inspiring a

you‘ve got this story that moderna has come up got this story that moderna has come up with a vaccineffective rate. slightly more effective than the pfizer vaccine and it‘s also easier to transport, so and it‘s also easier to transport, so there‘s lots of high hopes that there‘s going to be a vaccine that will be available in the uk to people and will be relatively easy to administer when there is an us of it. that could still be a few months away —— enough of it. the pfizer one isa away —— enough of it. the pfizer one is a vaccine that could be coming on strea m is a vaccine that could be coming on stream sooner, and all of this has been about how much the uk has, how much its body, and we found out today that it ordered 5 million and initially, the moderna vaccine wasn‘t one the uk had orders for. i think there might be some questions around why the order was put in today. we might come to that in a bit more detail, butjohn, the deputy chief officers of the result was brilliant news. he speaks in a language even tv presenters can understand. it conveys the message very, very well. h

itself ist -- moderna popping. folks hopeful we have an economy that could be able to normalize when this economy -- when this vaccine gets out there on a more widespread basis. this is bringing what we also saw last week. we have the travel and leisure stocks popping sharply higher. on the other hand, the stay-at-home trade, the zooms and the pelotons are down. interesting to see how much of our behavior trickles forward into the future. right now those stocks are being sold off. the one piece not quite fitting into the puzzle, bonds just about flat. bonds not selling off. that may stick to the more difficult months ahead as the vaccine is raging here in the u.s. -- the virus is raging here in the u.s. ahead of the vaccine getting out there. bonds more near-term looking at the reality. stocks more optimistic, doing with the s&p 500 does. later- alix: -- david: would be speaking with dr. celine gounder. paulsontime ago, henry appeared at the bloomberg new economy for them and set a comprehensive new approach to u.s

moderna just heard about this data yesterday afternoon. an independent safety and monitoring board told them the good news. i spoke yesterday with tal zaks, the chief medical officer of moderna. >> tell me how did it feel to hear that number, 94.5%? >> elizabeth, it's one of the greatest moments of my life and my career. it is absolutely amazing to me to be able to develop this vaccine and see the ability to prevent symptomatic disease with such high efficacy. >> now, pfizer and moderna both still have to apply to the fda for authorization on their vaccines. i spoke last night with dr. anthony fauci, he says that he thinks shots could start going into arms in the latter part of december. jim, poppy? >> that's really great news. we needed it this monday morning, elizabeth. thank you for that. >>> now let's get to some sad news and that is the surge across the country of infections, the situation particularly dire in the dakotas where both covid-19 hospitalizations and deaths are spiking. >> do you remember when spokes said this was just a b

moderna says the trials so far show the vaccine is almost 95% effective.ge of people including the over—65s, people with underlying medical conditions, and those from different ethnic backgrounds. and, crucially, it can be stored at normal refrigerated temperatures, making it much easier to distribute than the pfizer vaccine announced last week. there are currently around 50 vaccines being tested worldwide, and the latest success has raised hopes that others could be on the way. our medical editor, fergus walsh, reports. another dose of hope — and further evidence that vaccines will provide a way out of this pandemic. thank you. stunning early results from this trial, from us firm moderna, have eclipsed the strong results just a week ago from pfizer biontech. i broke into an ear—to—ear grin when i heard the numbers. it really exceeded our best hopes, and it is an incredibly exciting moment for us as a company, and as a world, as we start to develop tools to fight the virus. 30,000 volunteers in the us took part in the trials. half had two doses of the vacc

moderna itself sharply higher.fter the market, we did have news coming from brookshire and s.her hathawaye -- berkshire added to their portfolio in terms of health care. typically, health care a defensive space. with the virus, perhaps these additions have something to do with the virus. stocks have been down sharply on the day after moderna news about the virus came out. likingours, investors pfizer as well. all right, abigail doolittle, thank you so much for that round up. i want to get to airbnb's filing. the company disclosing details of its initial public offering plans for the first time, releasing financial results and previously confidential information on its operations. in ipo search that has largely defied the economic devastation inflicted by the pandemic. i want to bring in crystal, who has been running through what has just crossed. highlightse of the of what you have seen so far. crystal: as expected, we are seeing a bit more of a third quarter rebound. the revenue took a hit from the stomach for the

moderna is the only vaccine that uses mrna.it true that moderna is using it and why the skepticism? >> leslie, moderna and pfizer both use mrna, it is the genetic messenger that signals cells to make the protein the virus has in the protein signals year in immune system. that's new and that's why you are hearing the skepticism, it's never been used in humans before but here is the good news, it's out of your system in a day or two. so if you have flu-like symptoms or headaches, it doesn't last. it lasts a day were two and we are going to have a big job on our hands with vaccine compliance. but i would much rather feel a little bit about hangover for a day then get covid-19, i don't know about you. but i'm thinking we can overcome that. being given to thousands and thousands of people here, we are seeing safety. >> harris: we all survived college. some of us had a hangover maybe only once. [laughter] so yeah. so doctor, really quickly, from what we've been reading, we know that pfizer and others have different types of injection

moderna says this shows the vaccine is over 94% effective at preventing covid.e were 11 cases of severe disease, but none among those who got the vaccine. moderna, like pfizer, have used a completely new method for creating vaccines which doesn't need the virus itself. it uses the genes for the coronavirus spike protein. this synthetic code, known as rna, is created in the laboratory and forms the vaccine. this teaches the body to recognise and build an immune response to coronavirus. before we can all throw away our facemasks and ditch social distancing, we're going to need to protect the world from covid. that will require billions of doses of coronavirus vaccine, and it's why clinical trials must continue. like this one, which began today in southampton and other sites across the uk. the jab from the belgian firm janssen is one of six covid vaccines pre—ordered by the government. over time, we will learn which of those works better in different ages and different people with different conditions, and also how to use the vaccines in combinations to give people

and yesterday, it was news to moderna. an independent panel called the data and safety monitoring board analyzed these numbers and they told moderna about these results yesterday afternoon. let's take a listen to the chief medical officer at moderna, dr. tal zaches. >> tell me, how did it feel to hear that number, 94.5%? >> elizabeth, it's one of the greatest moments of my life and my career. it is absolutely amazing to me to be able to develop this vaccine and see the ability to prevent symptomatic disease with such high efficacy. >> now, neither pfizer nor moderna has applied to the fda for authorization on its vaccine. they can't do that quite yet. they need to accumulate some more safety data, but that is expected to happen very soon. i spoke yesterday with dr. anthony fauci. he says that he thinks that vaccinations could begin in the united states in the second half of december. alisyn, john? >> second half of december, which is really just a few weeks away at this point. but talk to me about the distribution pattern,

la compaqia moderna anuncia que hoy pediria la aprobacion borja: moderna pedirÍa el uso de vacunas emergencia la administraciÓn de aviación confirma el envÍo de los primeros vuelos chÁrter cargados con vacunas de pfizer hacia los estados unidos. la imagen de un doctor hispano abrazando a uno de sus pacientes en texas se hizo viral en redes. hoy su protagonista el doctor joseph aarÓn se conecta para contarnos la historia de esta conmovedora imagen. hoy es lunes de motivaciÓn. no te puedes perder la historia de josÉ hernÁndez que llegarÁ a las pantallas del mundo a travÉs de netflix. hoy nos acompaÑa para contarnos de su infancia trabajando en el campo hasta llegar a su espacio, si comenzamos. ♪ ♪ ♪ ♪ ♪ ♪ ¿quÉ tal? feliz lunes, esta es tu ediciÓn digital 30 de noviembre. yo soy borja voces, carolina tiene el dÍa libre. en las Últimas horas en laboratorio moderna anunciÓ que hoy le pedirÁ a la fda la aprobaciÓn de emergenciade su vacuna que arrojÓ no 24% de eficacia contra el coronavirus. esta farmacÉutica dijo que al mismo tiempo presentarÁ solicitudes de emergencia y autorizaciÓn para suvacuna

we've got to give moderna some love here. it is off its premarket highs but still up about 10% right now. the stock rose to a 52-week high on the news it broke today, preliminary trial data shows its coronavirus vaccine is 94.5% effective but there's more. remember on friday right here on "the claman countdown," dr. jacob glanville, one of these guys at the forefront of development for antibody treatments, et cetera, he showed you the lab quality freezers that are needed to keep most vaccines out there, including pfizer's covid shot, at a storage temperature of minus 94 degrees fahrenheit. this morning, moderna's ceo revealed his vaccine's cool factor. >> it's more a regular freezer, like your freezer at home, to store your food and ice creams. those freezers are widely available at pharmaceutical distribution centers because they are fda approved for them. so that's not a problem. the thing we're very excited is we used before to update [ indiscernible ] and now we have 30 days of study where you can take the product out of

this week it's moderna, which is based in massachusetts. both companies released preliminary findings from their phase three trials. today moderna said its vaccine is 94.5% effective at protecting people against the coronavirus. its trial involved 30,000 people. both pfizer and moderna now hope the fda will soon grant them emergency use authorization. >> so now what we're going to be looking for is, you know, any kind of long-term side effects, and they're going to be thinking about scaling up production. scaling up production for a vaccine, be it moderna or pfizer, is not going to be easy, and we need multiple vaccines out there because they are difficult to produce, and you need very specific types of production plants to produce them. >> so it's not a bad thing. it's not like who gets there first? it's the more the better, the more the merier? >> in this particular situation, that's the case. with vaccines, it's not always the first one that's going to be the best one. in this particular case, it seems like there are two very good and pr

moderna says it has produced a coronavirus vaccine nearly 95% effective.his comes as coronavirus cases in the u.s. top 11 million and hospital admissions at record levels. joe biden says political paralysis could hurany medical efforts. >> what do you see as th biggest threat to your transition given president npump'scedented attempt to obstruct and delay a smooth transfer of power? >> more people may die. if we don't coordinate. laura: the babies snatched from their mothersnd sold. shocking evidence of a thriving underground network in kenya. in the makings thise witnessed investigation shocked me to my core. as a woman, as a mother,s a canyon -- as kenyan. laura welcome to world news america on pbs and around the globe. more good news in the search for a cid vaccine. after trials in the u.s., moderna says it's ccine is almost 95% effective. it is one of 50 vaccines bein trials worldwide and its success, along with pfizer's, raises hopes others could be effective. our medical editor reports. >> another dose of hope and rther evidence that vaccines will pr

moderna stock prices, huge gain. moderna's vaccine is 94.5% effective so with the rapid development we now have two highly effective vaccines, that means we have a real shot at getting the virus under control next year, liked at the end of the covid tunnel. two down, two to come, johnson & johnson and astrazeneca. that's the main reason for the big monday morning rally with the dow jones up about 450 points. tao, 30000. if we gain 500 points the dow jones is at 30k, again in a one half percent. smaller game for the s&p and nasdaq slightly lower. that is the market. love the rally. hate this of violence. trump supporters attacked in washington dc last night with tens of thousands rallying peacefully, but after nightfall violence. a limited police presence and virtually no mention about this in the mainstream media and so far no statement from the biden harris camp. bernie sanders now says he has not met anyone who wants to defund the police. has he talked to aoc? editorial, the company ministration deserves credit for

moderna also is releasing new data on the effectiveness of its vaccine. it now says it is 94.1% effective against the virus. and listen to this, 100% effective at preventing the most severe cases of covid. >> meanwhile, a coordinator of the white house coronavirus task force says if you travel this thanksgiving, assume you're infected and stay home. dr. deborah birx, dr. anthony fauci and others are warning of a surge upon a surge in cases after holiday celebrations. this morning, more americans are hospitalized with coronavirus than ever before. more than 4 million new cases were reported in november. that's double the month before. cnn's lizbeth cohen joins us now with the breaking news on the vaccine. moderna applying for emergency use authorization and releasing new data about its trials, elizabeth? >> reporter: that's right, john. what's exciting about this new data is it's a much larger data set, so it's much more reliable than what they announced a few weeks ago. so let's take a look at what these percentages are. what they're showing is that their

. >>>♪ (música) (♪ música ) anuncian otra vacuna, los laboratorios moderna anuncian que su vacuna contra9 tienen 95 de eficacia anuncian que no necesitan tanto frío para conservarse como los demás . >> buenas tardes, con este anuncio son 2 de las vacunas que pueden estar disponibles con limitaciones a final de año, mercados financieros reciben la noticia con importantes noticias, además, este lunes (música) me siento con nervio, no solo por mí, temo por toda la gente del muelle . >> ahora iota, el huracán iota se acerca hacia honduras y nicaragua donde tocará tierra esta madrugada hay miles de evacuaciones en la zona, hace días tuvieron el huracán eta (hablan en inglés) más gente podría morir, el presidente electo asegura que más gente podría morir de covid-19 si donald trump obstaculiza la transición y dice que hay dinero para otro paquete de ayuda (gritos) vuelven a soñar, jóvenes dreamers celebran la decisión de un juez sobre acción diferida para llegados en la infancia (daca), los que hayan sido rechazados podrán aplicar nuevamente . >> noticias telemundo con josé díaz-balart (música

the distant light at the end of a long, long tunnel, early data suggests moderna vaccine is nearly 95%ective. so when will it be available to you. a million new cases in just one week. to stop the spread more governors announce new restrictions. no indoor dining, no in-person learning and as hospitals are straining to keep up, some sick ktients coming off life-support insist covid isn't real. >> they deny it their family members deny it. >> the first thing they are trying to communicate is it is all a hoax. >> o'donnell: plus as the crisis worsens, hunger grows. thousands of cars line up for food. costing lives, president-elect biden calls on president trump to start the official transition. >> more people may die if we don't coordinate. >> o'donnell: as michelle obama says this isn't a game and calls and calls on the to honor the president to honor the electoral process. breaking news, the president's plan to withdraw troops from iraq and afghanistan, why it is opposed by top military leaders. powerful new hurricane, a category five storm bears down on central america. scouts dishonor

the latest vaccine is made by the us firm moderna. earlier this month could cost lives. mr biden said more people might die from covid—19 unless the president worked with the incoming team to coordinate vaccination programmes. thousands of people have been evacuated from the coasts of honduras and nicaragua as hurricane iota bears down on the region damaged two weeks ago by another storm. forecasters say the hurricane threatens to destroy many homes, wreck power supplies and make the area affected uninhabitable for months.

moderna didn't need capital. i think they will show that in the next few weeks when their data comes about so bottom line is i feel very excited about the platform and these technologies >> but if pfizer can use this approach successfully, perhaps other big biotech companies will do the same thing, why would you need moderna >> well, i think some of the things that meg said i think are absolutely true and i would echo that number one is it makes sense to have similar but yet differentiated approaches, moderna's platform could show differentiated dwrat in elderly data and there are differences in all the way the drug is handled. it doesn't require negative degrees celsius, just in case something happened with one of them that there are other ones that would be able to supply the world. it does make sense that we would want multiple ones available and just as a a platform technology, the companies are definitely going off in different directions looking at different vaccines in different areas as well. >> we're obv

it was due to that very positive news from moderna. 94.5% positive news from moderna. 9a.5% effective was only two mondays ago, just over one week ago that we heard a similar story from pfizer and biontech, the drug they are producing has an effective rate of 90% suit was a broad—based rally in london, banks and retailers, they all performed well but the real stand—up performers were the travel stocks, transport socks and also hospitality and it makes sense because these are the industries which have been hit the hardest by the pandemic and arguably have the most to gain, should we have a coronavirus crisis put to bed. there is some real concern about certain airlines and certain travel operators. they are on the brink of collapse. good news of a vaccine be rolling out, and into the new year. would that prevent some of these companies going under, do you think? i think it would certainly assist smaller airlines in the pursuit of credit, should that be the case. there is already well—established government and bank of england lending schemes but some of the bigger airlines such as easy

moderna anuncia que su vacuna contra el covid-19 es mÁs del 94% efectiva.lmacenarlas en temperaturas tan bajas como la de pfizer. joe biden dice que morirÁn más personas y el presidente trump sigue rechazando coordinar con su equipo de transiciÓn la lucha contra la pandemia. ♪ ♪ locutor: este es un noticiero univisiÓn edición nocturna. patricia: muy buenas noches. vamos a comenzar con el catastrÓfico huracÁn iota. tocÓ tierra esta noche con la fuerza de un huracÁn de categorÍa 4 en las costas de nicaragua, con vientos de mÁs de 150 millas por hora. las fuertes lluvias que se sienten en otros paÍses de centroamÉrica podrÍan agravar la tragediaque ya viven los habitantes de las zonas devastadas, tras el paso de la tormenta eta. un paÍs que estÁ a la espera de los peores honduras. reportera: buenas noches, a esta hora el huracÁn iota , convertido en categorÍa 5, a1 toca territorio hondureÑo. empieza a sentirse en las zonas cercanas al paÍs. el poderoso huracÁn ya tocÓ tierra nicaragua. se espera que en las prÓximas horas llegue a honduras afectando todo el paÍ

you heard stefan bancel of moderna.as not publicly acknowledged at all when they could take up this public look at the moderna candidate. connell. connell: still all good news here so far with the vaccine. i'm sure they're pleased at the white house? reporter: they are. at least this was the message, in part one of messages coming from today to president trump, he took to twitter, said the following quote, moderna now applying for emergency vaccine approval. fda must act quickly. to be clear though, connell, and the fda has been very clear about this, they said the eua process is going to take weeks whoever it may be pfizer, moderna someone else. they want it to be thorough, they want it to be vetted and want it to be transparent. last thing we heard from the fda no matter who it will be it will be a several weeks process. connell. connell: makes sense, blake burman from the white house. we have reaction from an emergency room physician from global outreach doctors. good to have you back on the show. let's start with th

early phase three data from moder moderna's vaccine shows it's 94.5% effective. very close to pfizer vaccine's rate of effectiveness. alex azar says this morning's news is a game changer. >> here we are ten months from the date when this virus hit our shore and we have a second 90% plus effective vaccine for the american people. this is really a historic day. >> this vaccine news could not come at a more crucial time in this country. nearly 70,000 people were hospitalized with the virus yesterday alone, more than ever before in this pandemic. 15 states are reporting record hospitalizations, state and local leaders beginning to roll out measures to try to slow down the virus' spread, including some red state governors. let's get to correspondent elizabeth cohen with more news on the vaccine. great news in the span of a few days. tell us in particular how the moderna one works. >> mo der -- ma der nahas the efficacy and they don't seem to have side effects. and thirdly, for moderna, they don't need any special freezes you can use the freezes that are already in pha

we had a ceo of moderna on the network earlier talking about the moderna trials. >> -- [indiscernible, and we're discussing with the national cancer institute in the u.s. to start a study. >> dr. gregory poland is with us, group director of vaccine research at the mayo clinic. dr. poland, thank you for being with us. i want to start with an impossible question, the things we do not know. we know there is a lot we do not know yet about the front running vaccine. of the things we do not know, what do you consider most important? what could be most upsetting or offputting that has yet to be the issue that drops -- yet to be the shoe that drops? >> the hardest part is motor and a has not yet publish the data. it is the set -- the hardest part is motor and a has not -- moderna has not published the data. we do not have long-term durability tests or long-term safety data, and we do not yet understand, as the clip you just played showed, how the vaccine might work in the eldest of the elderly and people who are highly immunocompromised. so that needs to be done. >> what is the fact that it h

robert walker for more on the moderna vaccine. he is the chair of the department of medicine at the university of california san francisco, and he's also the author of the digital are doctor, hope, hype, and harm at the dawn of medicine's computer age. thank you, doctor, for being with us. >> thank you. >> so amid all the bad news of record covid cases and hospitalizations, some good news at last with moderna's covid-19 vaccine candidate proving to be nearly 95% effective. even better than pfizer's proposed vaccine announcement last week. what is your reaction to this news of a second vaccine option on the horizon? >> it's staggeringly wonderful. i think as a physician and a scientist, i'm supposed to be calm and dispassionate, but it almost makes you giddy how good it is. as of a month ago, we don't know for sure that any vaccine would work and hopeful they might prevent 2/3 of the cases but 95% is actually unbelievable. >> and moderna says they could start vaccinations at the end f. the year for front line workers and how differ

moderna, 94.5% efficacy in their trials, follows pfizer at 90%. up 13% for moderna.mall caps get a bid. big tech does not. tom: if you look at the morgan stanley note where they lift up their targets, people are beginning to recalibrate. i want to go back to the way we are seeing people lift up, up 7%, up 6%. i questioned if that is framed into people's minds. they are buying but they are not buying to be on board, buying to be a reachable target. 3900han: morgan stanley year end 2021. in a call on the bond market for a higher 10 year yield. as you said at the top of the -- lisa "lisa bramlett abramowicz, we are not getting the move in the bond market. lisa: is actually rolling over. barely any move at all on the 10 year yield. 1.45% and here yield. longer-term growth does not escalate that much. perhaps we return to a new normal but still slower growth with a lot of debt and an overhang from the pandemic. jonathan: in just a moment we will turn to a panel at the new economy forum, and on that panel will be blackstone's steve schwarzman. in the news in the financial

moderna says they've been working on this day and night. researchers and scientists have been in the lab the last several months. the efficacy rate is 94.5% effective, higher than pfizer's 90% effectively that was rolled out a few weeks ago. this study was done on about 30,000 people, and it was shown to be quite effective. moderna says they believe they can get this vaccine rolled out here in the u.s. as early as december. now, who it would go to remains unclear. likely first responders and the high-risk folks dr. fauci spoke about. i spoke to moderna's president, and he told me this. >> my hope is that it provides hope that we're going to beat this thing, and beat it sooner rather than later. the truth is, it is still going to be a lot of work to get there. this is an important milestone. we now know we have a vaccine that works and can protect against covid-19, including severe covid-19, which is terrific. but we now need to manufacture those doses, millions and millions of doses, as well as make sure that those are distributed to people

moderna inc. says its trial drug is 94% effective. news that has generated excitement around the world. it means the u.s. could have a second vaccine for emergency use this december with the u.k. also putting in an order and with the european union already locked in talks with the pharmaceutical company. catherine brings us more. >> raising the bar to a new level. moderna inc. announces that it's covid vaccine is almost 95% effective based on a late stage clinical trial with 30,000 participants. the laboratory's president said encouraging, much work remains to bdone. >> it was great news, we still need to complete the regulatory process which means completing the study, generating more data, follow-up safety data and then we need to get busy manufacturing. >> the company hopes to produce 20 million doses by the end of this year and is aiming to make between 500 million and a billion doses by next year. the eu commission described the news as encouraging on twitter. they hope to begin distributing

more than 30,000 people in the united states took part in moderna's phase 3 study.mong them 95 were confirmed to have covid-19 two weeks after the vaccine. 90 were observed in the placebo group, and five in the vaccinated group. 11 developed severe cases, all within the placebo group. based on their interim analysis of the data the firm estimates the vaccine had an estimated 94.5% efficacy and says there were no significant safety concerns. moderna is part of the united states operation wp spee ich as to accelerate the e hd of e programays the and dernaaccine wld b eas t administer bauseheaccine cabe stored at standar to a month.temraturesor up as oppos tthe pfizer vaccin which will require specialized storage to ensure temperates remain between minus 60 and minus 80 degrees celsius. if approved by regulators, moderna expects to have about 20 million doses ready to ship in the u.s. by the end of this year and is on track to manufacture up to 1 billion doses for global use in 2021. and that news from moderna has put investors on wall street in a buying mood. two of t

moderna says no one developed serious side effects. they plan to apply to the fda for authorization of the vaccine soon after more safety data later this month. dr. anthony fauci was just on the "today" show. he says he's excited about the results. >> the data is striking, quite impressive. 94.5% efficacy. there were 95 events, five in the vaccine group and 90 of them in the placebo group is quite impressive and really something that foretells impact on the outbreak. >> hovering about 500 up the dow jones already. >> the biden transition team and your family next year. "today in the bay's" tracie potts with more on this breaking news from overnight. >> reporter: the president won't accept the election results or direct his administration and the transition meetings are continuing to connect with the people they need to the president trump overnight tweeting that biden won. on twitter, about election fraud including early this morning tweeting that he won the election. the biden team, not only is the president-elect not getting access t

moderna one ups pfizer. bloomberg. ♪ manus: it is daybreak europe from our middle east headquarters. moderna's vaccine is shown to be 94.5% effective during late stage trials. we talked about this extensively yesterday. you have had 24 hours to think about the vaccine. what does it mean, in addition to pfizer? does it set the stage for multiples to come? thing is that people should not assume the moderna vaccine is better than the pfizer one based on very early data we have seen. the second thing is obviously the company, the product moderna has developed appears to have an easier logistics requirement with regards to the cold change, the lower temperature it needs to be kept at than pfizer's. the reality is we are going to have so many requirements that the companies will have to -- the vaccines will have to be used at the same time until we get more. what is the biggest challenge? is it distribution? >> that is an excellent question. , it is aribution mechanical process for want of a better phrase. we can

for moderna. 94.5% efficacious. for those of you not acquainted with the field of vaccine, that's extraordinary. that's almost to the level of what we see with measles which is 98% effective. that's what we are dealing with. the question is: what about how that will be rolled out? i use the word efficacious that, means what happens in the clinical trial. the word effective is what the ultimate impact of that vaccine will be on society. the only way you can get an effective program is when people take the vaccine. we will be talking to you about that. i hear a lot now when we made these announcements this past monday and then 2 mondays ago about reticence of people: did you rush this? is it really safe and efficacious? the process of the speed did not compromise at all safety nor did it compromise scientific integrity. it was a reflection of the extraordinary scientific advances in these times of vaccines which allowed us to did things in months that actually took years before. i really want to settle that concern th

moderna's is very similar. that is a two-day vaccine given over 20 days. they waitedstudy, two weeks to start counting responses. that is when your immune system promotes vaccines. you need a couple weeks there, a little bit of time after you get your doses, after you get immunized come to see that immune response start to spike up and you get the peak of protection. i think you are right on as far evidencewe see any that suggests after you get the first dose you are protected to a partial degree, or do you need to get both doses, 10, 14, something like that, some number of days to get that full degree of protection that we are seeing when we talk about 95% effectiveness? mentioned your beat is the pharmaceutical and biotech industry. here is your question right up that alley -- jim writes from massachusetts -- "are the vaccines at their least possible cost now, or is big pharma making a profit at human cost? also, how is patent protection affecting vaccine supply?" guest: that is a great question. no,nswer director, overall, they are at the least possible

but drugmaker moderna says it's formula is almost 95% effective. president trump are minding americans this is happening on his watch. investors were thrilled with today's news, the dow getting 471 to close at a record high for the first time since february, recouping its pandemic losses. the s&p 500 was up 42, the nasdaq jumped 95. however, the latest case numbers indicate a million new infections in just the past week. many state and local governments are now instituting new guidelines to try to curb the spread. all of this occurs against the backdrop of the president of posthumous ongoing efforts to challenge the results of the election. tonight, newly uncounted ballots are found during the ongoing recount in georgia and it appears those ballots will overwhelmingly benefit the president. more on that count in just a minute. president-elect joe biden's meantime saying this afternoon the consequent is a president trump's reluctance to coordinate on a transition will be "more people dying." chief white house correspondent john roberts tonight live

diminishing returns on the news out of moderna. question whether this is a sell the news moment. is it just today or is it something bigger. we will only know with time. some of the havens over last year urso are sharply higher, telling us some investors are hedging. for november, it is remarkable. 10%,&p 500 up more than the russell 2000, it's best month ever. standing out the most to me, the financials up nearly 20%. the best month going all the

the action agenda is not —— pfizer and moderna.ope for other diseases we don't know about in the future with yellow absolutely. these developments are really brand—new. we haven't got an mrna vaccine licence as of yet. so, what does this teach us? we really have a renaissance in vaccine development, and what we're learning at the moment because of all of these creative ways to develop the vaccines will be useful in the future because what you must remember is infectious diseases are a lwa ys remember is infectious diseases are always our adversary. there was sars in the past, mers and the middle east, what we know in the future is these viruses will continue to come and we will continue to need to be ready to defeat them with good vaccines of. good to speak to you. thank you very much indeed for joining us on bbc news. here in the uk, a major study has found the number of cases in england has fallen by about a third during the current national lockdown. some of the worst—affected areas, such as the north—west, have seen the biggest